Patents by Inventor Juana Maria Lugo Gonzalez

Juana Maria Lugo Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of PACAP for the treatment of viral infections in aquatic organisms
    Patent number: 9603900
    Abstract: The present invention relates to the use of pituitary adenylate cyclase activating polypeptide (PACAP) in the treatment of viral diseases and infectious diseases caused by viruses in aquatic organisms. PACAP, alone or combined with an antiviral molecule, demonstrated its effectiveness by increasing the survival of fish or crustaceans infected by viruses when it was administered orally, by injection or by immersion baths. Furthermore, it was observed that treated organisms keep or increase its weight as compared to infected and non-treated organisms. PACAP or PACAP-containing combinations decreased the viral load in tissues and organs susceptible to viral infections as it was determined by RT-PCR.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: March 28, 2017
    Assignee: CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
    Inventors: Mario Pablo Estrada Garcia, Juana Maria Lugo Gonzalez, Yamila Carpio Gonzalez, Carolina Tafalla Pineiro
  • Use of the PACAP as a molecular adjuvant for vaccines
    Patent number: 9549977
    Abstract: The present invention relates to the use of the pituitary adenylate cyclase activating peptide (PACAP) as a molecular adjuvant for vaccines. Among other applications, these vaccines may be used in the protection against infectious agents such as viruses, bacteria and ectoparasites affecting mammals, birds and aquatic organisms. The PACAP, combined with a particular antigen, demonstrates its effectiveness as adjuvant increasing the host immune response against that antigen. This type of response can be observed when the vaccine compositions or combinations that include PACAP are administered orally, by injection, or by immersion baths, in case of aquatic organisms.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: January 24, 2017
    Assignee: CENTRO DE INGENIERIA GENETICA Y BIOTECHNOLOGIA
    Inventors: Juana Maria Lugo Gonzalez, Yamila Carpio Gonzalez, Mario Pablo Estrada Garcia
  • USE OF PACAP FOR THE TREATMENT OF VIRAL INFECTIONS IN AQUATIC ORGANISMS
    Publication number: 20160030519
    Abstract: The present invention relates to the use of pituitary adenylate cyclase activating polypeptide (PACAP) in the treatment of viral diseases and infectious diseases caused by viruses in aquatic organisms. PACAP, alone or combined with an antiviral molecule, demonstrated its effectiveness by increasing the survival of fish or crustaceans infected by viruses when it was administered orally, by injection or by immersion baths. Furthermore, it was observed that treated organisms keep or increase its weight as compared to infected and non-treated organisms. PACAP or PACAP-containing combinations decreased the viral load in tissues and organs susceptible to viral infections as it was determined by RT-PCR.
    Type: Application
    Filed: August 28, 2015
    Publication date: February 4, 2016
    Inventors: Mario Pablo Estrada Garcia, Juana Maria Lugo Gonzalez, Yamila Carpio Gonzalez, Carolina Tafalla Pineiro
  • USE OF THE PACAP AS A MOLECULAR ADJUVANT FOR VACCINES
    Publication number: 20140294889
    Abstract: The present invention relates to the use of the pituitary adenylate cyclase activating peptide (PACAP) as a molecular adjuvant for vaccines. Among other applications, these vaccines may be used in the protection against infectious agents such as viruses, bacteria and ectoparasites affecting mammals, birds and aquatic organisms. The PACAP, combined with a particular antigen, demonstrates its effectiveness as adjuvant increasing the host immune response against that antigen. This type of response can be observed when the vaccine compositions or combinations that include PACAP are administered orally, by injection, or by immersion baths, in case of aquatic organisms.
    Type: Application
    Filed: August 24, 2012
    Publication date: October 2, 2014
    Applicant: Centro De Ingenieria Genetica y Biotecnologia
    Inventors: Juana Maria Lugo Gonzalez, Yamila Carpio Gonzalez, Mario Pablo Estrada Garcia
  • PACAP for aquatic organism culture
    Patent number: 8833306
    Abstract: The present invention is related to the use of variants of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) to stimulate the growth and to improve the immunological system of aquatic organisms. The variants of the peptide were provided by immersion, injection or as a food additive.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: September 16, 2014
    Assignee: Centro de Ingenieria Genetica Y Biotecnologia
    Inventors: Juana Maria Lugo González, Mario Pablo Estrada Garcia, Alina Rodriguez Mallon, Yamila Carpio González, Antonio Morales Rojas, Osmany Rodrigo González De Sosa, Reynold Morales Fernández, Fidel Francisco Herrera Miyares
  • USE OF PACAP FOR THE TREATMENT VIRAL INFECTIONS IN AQUATIC ORGANISMS
    Publication number: 20140087998
    Abstract: The present invention relates to the use of pituitary adenylate cyclase activating polypeptide (PACAP) in the treatment of viral diseases and infectious diseases caused by viruses in aquatic organisms. PACAP, alone or combined with an antiviral molecule, demonstrated its effectiveness by increasing the survival of fish or crustaceans infected by viruses when it was administered orally, by injection or by immersion baths. Furthermore, it was observed that treated organisms keep or increase its weight as compared to infected and non-treated organisms. PACAP or PACAP-containing combinations decreased the viral load in tissues and organs susceptible to viral infections as it was determined by RT-PCR.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 27, 2014
    Applicant: CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
    Inventors: Mario Pablo Estrada Garcia, Juana Maria Lugo Gonzalez, Yamila Carpio Gonzalez, Carolina Tafalla Piñeiro
  • NEUROPEPTIDES FOR AQUATIC ORGANISMS CULTURE
    Publication number: 20090176703
    Abstract: The present invention is related to the use of variants of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) to stimulate the growth and to improve the immunological system of aquatic organisms. The variants of the peptide were provided by immersion, injection or as a food additive.
    Type: Application
    Filed: November 20, 2006
    Publication date: July 9, 2009
    Applicant: CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
    Inventors: Juana Maria Lugo Gonzalez, Mario Pablo Estrada Garcia, Alina Rodriguez Mallon, Yamila Carpio Gonzalez, Antonio Morales Rojas, Osmany Rodrigo Gonzalez De Sosa, Reynold Morales Fernandez, Fidel Francisco Herrera Miyares